Saugel, B;Phillip, V;Moessmer, G;Schmid, RM;Huber, W
Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
Crit Care
2010
14
3
R90

Steimer, W
Pharmacogenetics and psychoactive drug therapy: ready for the patient?
Ther Drug Monit
2010
32
4
381-6

Müller, C;Schlichtiger, A;Balling, G;Steigerwald, U;Luppa, PB;Thaler, M
Standardized antigen preparation to achieve comparability of anti-beta2-glycoprotein I assays.
Thromb Res
2010
126
2
e102-9

Luppa, PB;Metzger, J;Schneider, H
Surface plasmon resonance biosensorics in urine proteomics.
Methods Mol Biol
2010
641
193-221

Hofmann, W;Sedlmeir-Hofmann, C;Ivandi?, M;Ruth, D;Luppa, P
PROTIS: use of combined biomarkers for providing diagnostic information on disease states.
Methods Mol Biol
2010
641
123-42

Müller, C;Thaler, M;Schlichtiger, A;Schreiegg, A;Balling, G;Steigerwald, U;Luppa, PB
?2-glycoprotein I-derived peptides as antigenic structures for the detection of antiphospholipid antibodies.
J Thromb Haemost
2010
8
9
2073-5

Junker, R;Schlebusch, H;Luppa, PB
Point-of-care testing in hospitals and primary care.
Dtsch Arztebl Int
2010
107
33
561-7

Mielsch, C;Zimmermann, A;Wagner, D;Matthes, B;Schlebusch, H;Luppa, PB
Point-of-care determination of neonatal bilirubin with the blood gas analyzer RapidLab 1265.
Clin Chem Lab Med
2010
48
10
1455-61

Roos, M;Oikonomou, D;von Eynatten, M;Luppa, PB;Heemann, U;Lutz, J;Baumann, M;Nawroth, PP;Bierhaus, A;Humpert, PM
Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.
Cardiovasc Diabetol
2010
9
48

Paslakis, G;Luppa, P;Gilles, M;Kopf, D;Hamann-Weber, B;Lederbogen, F;Deuschle, M
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
J Psychiatr Res
2010
44
8
556-560